INVO Fertility (IVF)
NASDAQ:IVF
Want to see IVF full AI Analyst Report?
IVF Stock Chart & Stats
$0.93
--
Market closed
$0.93
--
Day’s Range― - ―
52-Week Range$1.27 - $183.60
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.28M
Market Cap
$2.64M
Enterprise Value$6.50M
Total Cash (Recent Filing)$2.08M
Total Debt (Recent Filing)$3.40M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Aug 13, 2026EPS Estimate
-0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-112.91
Shares Outstanding1,786,035
10 Day Avg. Volume24,408,967
30 Day Avg. Volume8,279,900
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.06
Price to Sales (P/S)0.06
P/FCF Ratio-0.06
Enterprise Value/Market Cap2.46
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit3.27
Enterprise Value/Ebitda-2.57
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.9
Revenue Forecast (FY)$10.42M
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst's recommendation to upgrade shares to Buy reflects confidence in the company's revenue outlook related to its lead asset in cancer treatment.
Company StrategyThe merger of INVO Biosciences with NAYA Biosciences creates a strong focus on developing a portfolio of bifunctional antibodies.
Product DevelopmentThe company's portfolio is largely composed of bifunctional antibodies, which include promising treatments for various types of cancer.
Bears Say
Market EnvironmentRaising capital will likely take time in a particularly challenging market environment.
Regulatory ComplianceThe company received a letter from Nasdaq indicating that the company failed to file its 10-K on a timely basis and as such, no longer satisfies listing rules.
Strategic FocusThe inability of the strategy to shift focus to oncology in general and bispecifics in particular is a disappointment, in our view.
INVO Fertility News
IVF FAQ
What was INVO Fertility’s price range in the past 12 months?
INVO Fertility lowest stock price was $1.26 and its highest was $183.60 in the past 12 months.
What is INVO Fertility’s market cap?
INVO Fertility’s market cap is $2.64M.
When is INVO Fertility’s upcoming earnings report date?
INVO Fertility’s upcoming earnings report date is Aug 13, 2026 which is in 59 days.
How were INVO Fertility’s earnings last quarter?
Currently, no data Available
Is INVO Fertility overvalued?
According to Wall Street analysts INVO Fertility’s price is currently Overvalued.
Does INVO Fertility pay dividends?
INVO Fertility does not currently pay dividends.
What is INVO Fertility’s EPS estimate?
INVO Fertility’s EPS estimate is -0.7.
How many shares outstanding does INVO Fertility have?
INVO Fertility has 1,786,035 shares outstanding.
What happened to INVO Fertility’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of INVO Fertility?
Currently, no hedge funds are holding shares in IVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
INVO Fertility
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---